BackTalis Biomedical Overview

Talis Biomedical Cost of Revenue

Cost of Revenue analysis for TLIS.

Quarterly Cost of Revenue

$84000.00
1100% YoY

As of Jun 30, 2024

Annual Cost of Revenue (TTM)

$980000.00
72.74% YoY

Trailing 12 months ending Jun 30, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)